Relationship between 25-Hydroxyvitamin D and All-cause and Cardiovascular Disease Mortality - 18/05/13
, Rehan Qayyum, MD, MHS
Requests for reprints should be addressed to Muhammad Amer, MD, Johns Hopkins University, 600 North Wolfe Street, Osler 264, Baltimore, MD 21287Abstract |
Background |
Observational studies have suggested a strong relationship between 25(OH)D and all-cause and cardiovascular disease mortality. A few studies also have described a nonlinear trend for this relationship in population subgroups, but less is known about this relationship in healthy adults. We examined the presence of a nonlinear relationship between 25(OH)D and all-cause and cardiovascular disease mortality among healthy adults.
Methods |
We examined 10,170 participants (≥18 years of age) using National Health and Nutrition Examination Survey data (2001-2004) combined with National Death Index for vital status information through December 2006. Cox proportional hazard models with spline (single knot at population median of 25[OH]D) were fit to estimate hazard ratios (HRs) for all-cause and cardiovascular disease mortality for each 10-unit increase in serum 25(OH)D. Models were adjusted for demographic and conventional cardiovascular disease risk factors.
Results |
Mean age of study participants was 46.6 (20.5) years, while median (interquartile range) 25(OH)D was 21 (15-27) ng/mL. After a median follow-up of 3.8 years (range 2.8-4.9), 509 all-cause and 184 cardiovascular diseases-related deaths were observed. In univariate analysis, 25(OH)D decreased hazards of all-cause (HR 0.59; 95% confidence interval [CI], 0.45-0.77) and cardiovascular disease (HR 0.56; 95% CI, 0.38-0.82) mortality below but not above its population median. In adjusted models, 25(OH)D retained the inverse association for all-cause (HR 0.54; 95% CI, 0.35-0.84) and cardiovascular disease (HR 0.50; 95% CI, 0.26-0.98) mortality below but not above its population median.
Conclusions |
We found an inverse association between 25(OH)D and all-cause and cardiovascular disease mortality in healthy adults with serum 25(OH)D levels of ≤21 ng/mL. Clinical trials for the primary prevention of cardiovascular disease with 25(OH)D supplementation may target healthy adults with serum 25(OH)D levels of ≤21 ng/mL to validate these findings.
Le texte complet de cet article est disponible en PDF.Keywords : All-cause mortality, Cardiovascular disease mortality, NHANES, 25(OH)D, Vitamin D
Plan
| Funding: Rehan Qayyum was supported by National Institute of Health grant No. 1K23HL105897-01. |
|
| Conflict of Interest: None. |
|
| Authorship: Both authors had access to the data and a role in writing the original manuscript. |
Vol 126 - N° 6
P. 509-514 - juin 2013 Retour au numéro
Article précédent
- Systolic Blood Pressure and Cardiovascular Outcomes During Treatment of Hypertension
- Michael A. Weber, George L. Bakris, Allen Hester, Matthew R. Weir, Tsushung A. Hua, Dion Zappe, Bjorn Dahlof, Eric J. Velazquez, Bertram Pitt, Kenneth Jamerson
- Prevalence, Extent, and Independent Predictors of Silent Myocardial Infarction
- Nisha Arenja, Christian Mueller, Niklas F. Ehl, Miriam Brinkert, Katharina Roost, Tobias Reichlin, Seoung Mann Sou, Thomas Hochgruber, Stefan Osswald, Michael J. Zellweger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?